![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
20
Beijing Gingko Group Biological Technology Co., Ltd. Beijing Cn, based in U.S.A, is a pharmaceutical company.
One of their significant offerings is Ginkgo dry extract, refined and quantified, DER: 40-50:1, supported by a 'Expired' Certificate of Suitability (CEP) with the number R0-CEP 2011-218 - Rev 00
This Herbal Type CEP, issued on June 28, 2013, remains in force until July 17, 2018, ensuring its reliability within the pharmaceutical industry.
Substance Number 1827 associated with this CEP further emphasizes